Description

Morcher's 67G ANIRIDIA IOL is a specialized intraocular lens designed to address the unique challenges faced by patients with partial or total iris deficiency, known as aniridia. This condition may be congenital or result from trauma, and the lens is crafted to enhance visual outcomes by reducing glare disability and photophobia. It also aims to improve cosmesis following cataract surgery.

Design Features

• Iris Mimicking: The lens features a peripheral colored region that resembles the natural iris, available in various pigmentation options. This design helps to reduce photophobia through tinting, providing comfort in bright conditions.
• Biconvex Structure: The lens includes a central 5.0 mm transparent optical zone, surrounded by a diaphragm treated with black co-polymer, enhancing visual clarity.

Implantation Versatility

The 67G ANIRIDIA IOL can be implanted within the capsular bag or scleral-fixated in cases of extreme subluxation. Its dimensions include a 12.5 mm overall diameter and a 10 mm diaphragm diameter, requiring a corneal incision of at least 11 mm for insertion.

Material Composition

Crafted from poly(methyl methacrylate) (PMMA) and black co-polymer, the lens is designed for durability and compatibility with the eye's natural structures.

Clinical Benefits

• Visual Acuity Improvement: Clinical outcomes indicate significant enhancement in best-corrected visual acuity and a reduction in glare for most patients.
• Low Complication Rates: The lens demonstrates a low incidence of mild postoperative anterior uveitis, with no reported cases of secondary glaucoma, underscoring its safety and effectiveness.

Morcher's innovative approach in the 67G ANIRIDIA IOL offers a tailored solution for individuals seeking improved visual function and comfort, addressing the specific needs associated with aniridia.